-
Dec 8, 2019, 7:15 pm418 pts
The Green FundBotanix Pharma moves ahead on trialing its unique cannabinoid formulation BTX 1702 for papulopustular rosacea. Botanix Pharmaceuticals Limited has announced that it has received ethics approval for a Phase 1b clinical study involving BTX 1702, a synthetic cannabidiol treatment for papulopustular rosacea. BTX…
Trending Today on NewsBudz
NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.
Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.
